Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study.

about

Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study.

Item

http://www.wikidata.org/entity/Q55402007

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Efficacy of tadalafil treatmen ...... -randomized comparative study.

@en

Efficacy of tadalafil treatmen ...... -randomized comparative study.

@nl

type

Item

label

Efficacy of tadalafil treatmen ...... -randomized comparative study.

@en

Efficacy of tadalafil treatmen ...... -randomized comparative study.

@nl

prefLabel

Efficacy of tadalafil treatmen ...... -randomized comparative study.

@en

Efficacy of tadalafil treatmen ...... -randomized comparative study.

@nl

P1476

Efficacy of tadalafil treatmen ...... -randomized comparative study.

@en

P2093

Mehmet İlker Gökce

http://www.w3.org/2001/XMLSchema#string

Mete Özkıdık

http://www.w3.org/2001/XMLSchema#string

Önder Yaman

http://www.w3.org/2001/XMLSchema#string

P2860

Current use of phosphodiesterase inhibitors in urology

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.

Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.

Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.

Tadalafil.

EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.

Update on AUA guideline on the management of benign prostatic hyperplasia.

The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.

Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.

Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink

P304

294-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5152/TUD.2018.46666

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29799405

http://www.w3.org/2001/XMLSchema#string

P932

6016656

http://www.w3.org/2001/XMLSchema#string